Group | Studies (n) | RR (95% CI) | P | Heterogeneity test | |
---|---|---|---|---|---|
P | I2 (%) | ||||
Total | 7 | 0.89(0.57ā1.37) | 0.58 | 0.05 | 52 |
Design | |||||
āRandomized controlled trials | 4 | 0.84(0.49ā1.45) | 0.53 | 0.11 | 51 |
āNon-randomized controlled trials | 1 | 0.27(0.06ā1.27) | 0.10 | NA | NA |
āProspective Cohort study | 2 | 1.26(0.70ā2.27) | 0.45 | 0.23 | 32 |
Area | |||||
āAsia | 5 | 0.68(0.47ā1.00) | 0.05 | 0.39 | 3 |
āEurope | 2 | 1.61(1.03ā2.52) | 0.04 | 0.85 | 0 |
Publication year | |||||
āāā¤ā2015 | 3 | 0.64(0.21ā1.96) | 0.43 | 0.02 | 74 |
āā>ā2015 | 4 | 1.08(0.75ā1.53) | 0.69 | 0.36 | 7 |
Quality score | |||||
āāā¤ā7 | 3 | 0.89(0.38ā2.08) | 0.78 | 0.07 | 62 |
āā>ā7 | 4 | 0.84(0.49ā1.45) | 0.53 | 0.11 | 51 |